Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ondansetron, quantity: 4 mg - tablet, orally disintegrating - excipient ingredients: microcrystalline cellulose; lactose monohydrate; mannitol; aspartame; magnesium stearate; crospovidone; colloidal anhydrous silica; flavour - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ondansetron, quantity: 8 mg - tablet, orally disintegrating - excipient ingredients: silicified microcrystalline cellulose; microcrystalline cellulose; mannitol; aspartame; crospovidone; magnesium stearate; colloidal anhydrous silica; flavour - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ondansetron, quantity: 4 mg - tablet, orally disintegrating - excipient ingredients: magnesium stearate; silicified microcrystalline cellulose; crospovidone; aspartame; microcrystalline cellulose; mannitol; colloidal anhydrous silica; flavour - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

United States - English - NLM (National Library of Medicine)

sydon labs llc - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see warnings and precautions (5)] celecoxib is incelecoxib is indicated for relief of the signs and symptoms of oa [see clinical studies (14.1)] celecoxib is indicated for relief of the signs and symptoms of ra [see clinical studies (14.2)] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] celecoxib is indicated for the relief of signs and symptoms of as [see clinical studies (14.4)] celecoxib is indicated for the management of ap in adults [see clinical studies (14.5)] celecoxib is indicated for the treatment of pd [see clinical studies (14.5)] celecoxib is contraindicated: • in patients with known hypersensitivity to celecoxib, aspirin, or other nsaids. • in patients who have demonstrated allergic

United States - English - NLM (National Library of Medicine)

bowyn labs, llc - selenium sulfide (unii: z69d9e381q) (selenium sulfide - unii:z69d9e381q) - this product is a liquid antiseborrheic, antifungal preparation useful for the treatment of seborrheic dermatitis of the scalp, dandruff and tinea versicolor. urea hydrates and is useful for conditions such as dry scalp. this product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

United States - English - NLM (National Library of Medicine)

artesa labs, llc - flurandrenolide (unii: 8eul29xuqt) (flurandrenolide - unii:8eul29xuqt) - nolix ™ cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in patients with a history of hypersensitivity to any of components of the preparation.

United States - English - NLM (National Library of Medicine)

alembic labs llc - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - bisoprolol fumarate   is indicated in the management of hypertension. it may be used alone or in combination with other antihypertensive agents. bisoprolol fumarate  is contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree av block, and marked sinus bradycardia.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - budesonide, quantity: 1 mg - tablet, orally disintegrating - excipient ingredients: magnesium stearate; mannitol; macrogol 6000; sodium acid citrate; sodium dihydrogen citrate; sodium bicarbonate; sucralose; povidone; docusate sodium - jorveza is indicated for the treatment of eosinophilic esophagitis (eoe) in adults

United States - English - NLM (National Library of Medicine)

artesa labs, llc - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide ointment, usp 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - budesonide, quantity: 0.5 mg - tablet, orally disintegrating - excipient ingredients: magnesium stearate; mannitol; macrogol 6000; sodium acid citrate; sodium dihydrogen citrate; sodium bicarbonate; sucralose; povidone; docusate sodium - jorveza? is indicated for the treatment of eosinophilic oesophagitis (eoe) in adults.